IRIS
GALLO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.150
AS - Asia 4.974
NA - Nord America 4.604
SA - Sud America 839
AF - Africa 68
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 21.650
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 7.150
US - Stati Uniti d'America 4.509
SG - Singapore 1.670
IT - Italia 1.228
CN - Cina 1.056
IE - Irlanda 1.011
HK - Hong Kong 759
BR - Brasile 694
VN - Vietnam 613
GB - Regno Unito 381
DE - Germania 337
UA - Ucraina 284
KR - Corea 221
JP - Giappone 170
IN - India 157
SE - Svezia 140
AT - Austria 133
TR - Turchia 118
FR - Francia 114
FI - Finlandia 102
GR - Grecia 71
NL - Olanda 67
AR - Argentina 64
BD - Bangladesh 51
CA - Canada 38
MX - Messico 32
BE - Belgio 23
IQ - Iraq 22
PL - Polonia 22
EC - Ecuador 21
ES - Italia 17
ID - Indonesia 17
MA - Marocco 17
PK - Pakistan 17
CO - Colombia 16
PY - Paraguay 16
ZA - Sudafrica 15
PH - Filippine 12
CZ - Repubblica Ceca 11
IR - Iran 11
UZ - Uzbekistan 11
KE - Kenya 9
MY - Malesia 9
AU - Australia 8
CH - Svizzera 8
CL - Cile 8
UY - Uruguay 8
DZ - Algeria 7
RO - Romania 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
BG - Bulgaria 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
EG - Egitto 5
IL - Israele 5
LT - Lituania 5
SA - Arabia Saudita 5
TW - Taiwan 5
JM - Giamaica 4
KZ - Kazakistan 4
NI - Nicaragua 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
TN - Tunisia 4
AM - Armenia 3
EE - Estonia 3
ET - Etiopia 3
EU - Europa 3
JO - Giordania 3
KW - Kuwait 3
LV - Lettonia 3
NG - Nigeria 3
NP - Nepal 3
PE - Perù 3
PT - Portogallo 3
AL - Albania 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CY - Cipro 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
MK - Macedonia 2
SM - San Marino 2
AQ - Antartide 1
BB - Barbados 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
Totale 21.637
Salva come PNG Salva come JPEG
Città #
Moscow 2.579
Dublin 1.009
Singapore 774
Hong Kong 743
Santa Clara 616
San Jose 528
Jacksonville 450
Chandler 387
Ashburn 221
Seoul 216
Ho Chi Minh City 200
Hefei 184
Naples 175
Hanoi 148
Beijing 135
Princeton 129
New York 120
Vienna 117
Caserta 115
Ann Arbor 113
Roxbury 105
Los Angeles 101
Bengaluru 99
Medford 94
The Dalles 89
Dallas 66
São Paulo 65
Bremen 62
Wilmington 60
Munich 59
Rome 57
Woodbridge 55
Boardman 53
Milan 46
Nanjing 46
Norwalk 42
San Mateo 40
Cambridge 39
Haiphong 34
Da Nang 32
Napoli 32
Orem 28
Nuremberg 27
Des Moines 26
London 25
Amsterdam 24
Aversa 23
Brussels 23
Memphis 23
Tokyo 23
Houston 21
Quarto 21
Falkenstein 20
Jinan 20
Frankfurt am Main 19
Warsaw 18
Atlanta 17
Chennai 17
Rio de Janeiro 16
Shenyang 16
Thái Bình 16
Istanbul 15
Mountain View 15
Stockholm 15
Chicago 14
Guangzhou 14
Hải Dương 14
Turku 14
Belo Horizonte 13
Brooklyn 13
Montreal 13
Shanghai 13
Turin 13
Verona 13
Curitiba 12
Genoa 12
Guayaquil 12
Manchester 12
San Francisco 12
Brasília 11
Guarulhos 11
Helsinki 11
Phoenix 11
Redwood City 11
Reggio Emilia 11
Auburn Hills 10
Caivano 10
Campinas 10
Ercolano 10
Lappeenranta 10
Mexico City 10
Ninh Bình 10
Tashkent 10
Baghdad 9
Denver 9
Johannesburg 9
Miami 9
New Delhi 9
São José do Rio Preto 9
Tianjin 9
Totale 11.106
Salva come PNG Salva come JPEG
Nome #
Anxiety in Multiple Sclerosis: Psychometric properties of the State-Trait Anxiety Inventory 667
Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume 211
Default mode network changes in multiple sclerosis: A link between depression and cognitive impairment? 207
Computer-aided cognitive rehabilitation improves cognitive performances and induces brain functional connectivity changes in relapsing remitting multiple sclerosis patients: an exploratory study. 199
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus. 193
Advantages of QBI in TBSS analyses. 187
Cognitive impairment in CKD patients: a guidance document by the CONNECT network 182
A simple measure of cognitive reserve is relevant for cognitive performance in MS patients 181
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study. 177
Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study. 176
Distributed changes in default-mode resting-state connectivity in multiple sclerosis 176
Visual resting-state network in relapsing-remitting MS with and without previous optic neuritis 175
Cognitive reserve and neuropsychological performance in multiple sclerosis: A meta-analysis 175
Fatigue in multiple sclerosis: The contribution of occult white matter damage. 173
Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study. 167
Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. 167
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 165
Frontotemporal cortical thinning in amyotrophic lateral sclerosis. 164
Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod 161
Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience? 160
BDNF Val66Met polymorphism and brain volumes in multiple sclerosis 158
Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures 158
A Combined Use of Radiomics and Connectomics to Classify Sex and Age in Healthy Subjects: The New “Radioconnectomics” Paradigm 157
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis. 155
A multiparametric brain and cord MR imaging study of a patient with Hirayama disease. 150
Assessing response to interferon-β in a multicenter dataset of patients with MS 150
Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosis 149
Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence 148
Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS 145
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab 144
A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis 143
A semiautomatic method for multiple sclerosis lesion segmentation on Dual-Echo MR imaging: Application in a multicenter context 142
Quality of life in women with multiple sclerosis and overactive bladder syndrome 141
Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis 141
The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis 141
Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod 140
INFRATENTORIAL PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN A PATIENT TREATED WITH FLUDARABINE AND RITUXIMAB 139
Extra-motor involvement in ALS patients: a cortical thickeness 3T MRI study 139
Fatigue in multiple sclerosis: The contribution of resting-state functional connectivity reorganization 139
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 138
Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis 138
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients. 137
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS 137
Does cognitive reserve play any role in multiple sclerosis? A meta-analytic study 137
Two-year macular volume assessment in multiple sclerosis patients treated with fingolimod 137
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 136
T(1) cortical hypointensities and their association with cognitive disability in multiple sclerosis 136
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy. 136
Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab 136
Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab 136
Epidemiologic Data of Vitamin D Deficiency and Its Implication in Cardio-Cerebrovascular Risk in a Southern Italian Population 135
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 135
An MT MRI study of the cervical cord in clinically isolated syndromes suggestive of MS 132
Dilated perivascular spaces and fatigue: is there a link? Magnetic resonance retrospective 3Tesla study 132
The role of diet in multiple sclerosis: A review 132
Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study (Journal of Neurology, (2022), 269, 3, (1610-1617), 10.1007/s00415-021-10737-w) 132
Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter Study 130
Consensus of algorithms for lesion segmentation in brain MRI studies of multiple sclerosis 130
Informing MS patients on treatment options: a consensus on the process of consent taking 130
Cognitive reserve predicts long-term cognitive trajectories in relapsing-remitting multiple sclerosis 129
Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis 129
Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis 129
A real-world study of alemtuzumab in a cohort of Italian patients 129
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative 127
Signs and symptoms of COVID-19 in patients with multiple sclerosis 127
Proton spectroscopic imaging - Principles and clinical applications in neurology 127
Use of Transglutaminase 2 mRNA expression in peripheral blood mononuclear cells in patients with Radiologically Isolated Syndrome as a neuroinflammation biomarker: A preliminary study. 126
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 126
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 125
Functional gradients reveal cortical hierarchy changes in multiple sclerosis 124
Vocabulary knowledge as a reliable proxy of cognitive reserve in multiple sclerosis: a validation study 124
Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution 124
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: A MAGNIMS Study 122
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients 122
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases. 122
Post-contrast MRI in multiple sclerosis: Towards a judicious use of gadolinium-based contrast agents 121
Brain atrophy and fatigue in relapsing-remitting multiple sclerosis patients: a 3T study 121
dVRS and Fatigue: is there a link? Magnetic Resonance retrospective 3T study 121
The Contribution of Resting State Networks to the Study of Cortical Reorganization in MS. 121
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs 120
Quality and Quantity of Diffuse and Focal White Matter Disease and Cognitive Disability of Patients with Multiple Sclerosis 119
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study 119
Validity and reproducibility of the Italian version of the patient determined disease steps scale in people with multiple sclerosis 119
Coping strategies in relapsing-remitting multiple sclerosis non-depressed patients and their associations with disease activity 119
Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey 118
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study. 118
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 117
Mean diffusivity and fractional anisotropy histogram analysis of the cervical cord in MS patients 117
Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study 117
Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability 117
Functional correlates of cognitive dysfunction in multiple sclerosis: A multicenter fMRI Study. 116
Multiparametric MRI in a patient with adult-onset leukoencephalopathy with vanishing white matter 116
Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI 116
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: The importance of intrathecal MOG-IgG synthesis 115
Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years 115
Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype 115
Clinical and MRI features contributing to the clinico-radiological dissociation in a large cohort of people with multiple sclerosis 114
Morphostructural MRI abnormalities related to neuropsychiatric disorders associated to multiple sclerosis. 114
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group. 113
Malattie del Sistema nervoso Autonomo 113
Totale 14.477
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.234
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.234
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 0 0 0 0 0 0 30
2021/2022945 53 15 19 35 287 27 25 40 61 65 70 248
2022/20231.778 179 22 32 127 166 132 6 85 941 27 26 35
2023/20241.058 71 38 53 105 262 120 69 29 36 21 107 147
2024/20253.086 22 33 43 91 553 369 414 230 465 369 282 215
2025/202612.730 523 762 711 629 1.065 6.646 912 462 381 276 242 121
Totale 22.128